Table 2.
Experimental group | Body weight | Temperature | Respiratory rate |
---|---|---|---|
Uninjured-infected over time (compared with pre-infection baseline) | *p = 0.0147 at day 1 | *p < 0.05 at days 1, 4–5 | *p < 0.05 at days 1,5 |
*p = 0.0116 at day 2 | **p < 0.01 at days 2,7 | **p < 0.01 at days 2–3 | |
NS at days 3–10 | NS at days 3, 8–10 | NS at days 4, 6–10 | |
T3Tx-Saline + infection over time (compared with pre-infection baseline) | *p < 0.05 at days 2–10 | **p = 0.0078 at day 1 | **p < 0.01 at days 1–2 |
***p = 0.0007 at day 2 | ***p < 0.001 at days 3–4 | ||
*p = 0.0169 at day 7 | *p < 0.05 at days 5–9 | ||
NS at days 3–6, 8–10 | NS at day 10 | ||
T3Tx-XPro1595 + infection over time (compared with pre-infection baseline) | *p < 0.05 at day 1–9 | *p < 0.05 at days 1,7 | **p < 0.01 at days 1,4,6 |
NS at day 10 | **p = 0.0031 at day 2 | ***p < 0.001 at days 2–3 | |
NS at days 3–6, 8–10 | *p = 0.0101 at day 5 | ||
NS at days 7–10 | |||
T3Tx-Saline + infection versus uninjured-infected | NS at days 0–3 | *p = 0.0384 at day 2 | ***p = 0.0001 at day 1 |
*p = 0.0117 at day 4 | NS at days 1, 3–10 | ****p < 0.0001 at days 2–4 | |
****p < 0.0001 at days 5–10 | **p = 0.0015 at day 5 | ||
NS at days 6, 8–10 | |||
*p = 0.0454 at day 7 | |||
T3Tx-XPro1595 + infection versus Uninjured-infected | NS at days 0–3 | NS at days 1–10 | *p = 0.0367 at day 1 |
**p = 0.0016 at day 4 | ****p < 0.0001 at day 2 | ||
****p < 0.0001 at days 5–6 | **p < 0.01 at days 3–4 | ||
***p = 0.0003 at day 7 | NS at days 5–10 | ||
*p < 0.05 at days 8–9 | |||
NS at day 10 | |||
T3Tx-Saline + infection versus T3Tx-XPro1595 + infection | NS at day 0–8 | NS at days 1–10 | NS at days 1, 3–10 |
*p = 0.0293 at day 9 | **p = 0.0085 at day 2 | ||
**p = 0.0067 at day 10 |
NS, nonsignificant.